{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.88G>C",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "C",
            "position": "88"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation"
        },
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation"
        },
        {
          "HGVS": "NM_000345.4:c.[88G>C;157G>A]",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Protein Change": {
            "ref": "N.D.",
            "alt": "N.D.",
            "position": "N.D."
          },
          "Description in input context": "Double mutant A53T/A30P"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "Circular Dichroism Spectroscopy",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant Human a-Synuclein",
        "Description": "Human a-Syn cDNAs (wild-type, mutant A53T, mutant A30P, and double mutant A53T/A30P) were overexpressed in Escherichia coli BL21 (DE3)."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A30P a-Synuclein does not bind to POPC/bPS vesicles and fails to undergo conformational transition from random coil to a-helical structure."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "A53T a-Synuclein binds to POPC/bPS vesicles and undergoes conformational transition similar to wild-type a-Synuclein."
        },
        {
          "Variant": "NM_000345.4:c.[88G>C;157G>A]",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Double mutant A53T/A30P a-Synuclein does not bind to POPC/bPS vesicles and fails to undergo conformational transition, similar to A30P."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Three scans per sample were averaged for CD spectroscopy."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-Synuclein was used as a positive control for membrane binding."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "CD values at 222 nm from three to four separate experiments were averaged, and standard deviations were indicated."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Increased ellipticity at 222 nm indicating a-helical conformation upon binding to vesicles.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "No significant change in ellipticity at 222 nm, indicating failure to transition to a-helical conformation.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Ultracentrifugation and Western Blot",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant Human a-Synuclein",
        "Description": "Brain PE/brain PS (1:1 w/w) MLVs were mixed with either wild-type or A30P a-Synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Barely detectable levels of A30P a-Synuclein were found in the membrane pellet, indicating significantly impaired binding."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Not specifically tested in ultracentrifugation experiments in the provided text."
        },
        {
          "Variant": "NM_000345.4:c.[88G>C;157G>A]",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Not specifically tested in ultracentrifugation experiments in the provided text."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-Synuclein was used as a positive control for membrane binding."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Wild-type a-Synuclein ultracentrifuged in the absence of MLVs served as a control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Significant presence of a-Synuclein in the membrane pellet indicating binding.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Minimal or no presence of a-Synuclein in the membrane pellet indicating impaired binding.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Low-Angle X-ray Diffraction",
      "Material used": {
        "Material Source": "Recombinant Protein",
        "Material Name": "Recombinant Human a-Synuclein",
        "Description": "MLVs of bPE/bPS were used with wild-type or A30P a-Synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.88G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "A30P a-Synuclein did not significantly alter the repeat spacing of lipid bilayers, indicating defective binding."
        },
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Not specifically tested in X-ray diffraction experiments in the provided text."
        },
        {
          "Variant": "NM_000345.4:c.[88G>C;157G>A]",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Not specifically tested in X-ray diffraction experiments in the provided text."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type a-Synuclein was used as a positive control for altering repeat spacing in lipid bilayers."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Lipid bilayers in the absence of a-Synuclein served as a control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Significant increase in repeat spacing of lipid bilayers indicating binding.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "No significant change in repeat spacing of lipid bilayers indicating defective binding.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}